Reactive oxygen species and the cardiovascular system

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Taverne, Yannick J H J ^a   Bogers, Ad J J C ^a   Duncker, Dirk J ^a   Merkus, Daphne ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR HOMEOSTASIS; DELETERIOUS EFFECTS; OXYGEN CONSUMPTION; PATHOLOGICAL CONDITIONS; REACTIVE OXYGEN SPECIES;

CARDIOVASCULAR SYSTEM; FREE RADICALS;

OXYGEN;

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; DOCOSAHEXAENOIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA ORYZANOL; INTERLEUKIN 1; NICOTINIC ACID; OMEGA 3 FATTY ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA; XANTHINE; XANTHINE OXIDASE;

ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; HYPOXIA; ISCHEMIA; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; REPERFUSION; REVIEW; SIGNAL TRANSDUCTION; SMOKING; ANIMAL; CELLS; METABOLISM; PATHOLOGY;

ANIMALS; CARDIOVASCULAR SYSTEM; CELLS; HUMANS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84878303591     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/862423     Document Type: Review

References (128)

1. Papa S., Skulachev V. P., Reactive oxygen species, mitochondria, apoptosis and aging. Molecular and Cellular Biochemistry 1997 174 1-2 305 319 2-s2.0-0030809576 10.1023/A:1006873518427 (Pubitemid 27404207)
2. Papaharalambus C. A., Griendling K. K., Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends in Cardiovascular Medicine 2007 17 2 48 54 2-s2.0-33846818459 10.1016/j.tcm.2006. 11.005 (Pubitemid 46205327)
3. Dröge W., Free radicals in the physiological control of cell function. Physiological Reviews 2002 82 1 47 95 2-s2.0-0036086130 (Pubitemid 34654215)
4. Chen Q., Vazquez E. J., Moghaddas S., Hoppel C. L., Lesnefsky E. J., Production of reactive oxygen species by mitochondria: central role of complex III. Journal of Biological Chemistry 2003 278 38 36027 36031 2-s2.0-0141815741 10.1074/jbc.M304854200 (Pubitemid 37139922)
5. Turrens J. F., Mitochondrial formation of reactive oxygen species. Journal of Physiology 2003 552 2 335 344 2-s2.0-0142150051 10.1113/jphysiol. 2003.049478 (Pubitemid 37321833)
6. Charles R. L., Eaton P., Redox signalling in cardiovascular disease. Proteomics 2008 2 6 823 836 2-s2.0-46749129745 10.1002/prca.200780104 (Pubitemid 351943764)
7. Lopes R. D., Li L., Granger C. B., Wang T. Y., Foody J. M., Funk M., Peterson E. D., Alexander K. P., Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes. American Journal of Medicine 2012 125 9 897 905 10.1016/j.amjmed.2012.04.006
8. Vermeer F., Simoons M. L., Lubsen J., Reduced frequency of ventricular fibrillation after early thrombolysis in myocardial infarction. The Lancet 1986 1 8490 1147 1148 2-s2.0-0022595561 (Pubitemid 16109975)
9. Griendling K. K., FitzGerald G. A., Oxidative stress and cardiovascular injury part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003 108 16 1912 1916 2-s2.0-0142055950 10.1161/01.CIR.0000093660.86242.BB (Pubitemid 37296532)
10. Raha S., Robinson B. H., Mitochondria, oxygen free radicals, disease and ageing. Trends in Biochemical Sciences 2000 25 10 502 508 2-s2.0-0034306267 10.1016/S0968-0004(00)01674-1
11. Cai H., Harrison D. G., Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research 2000 87 10 840 844 2-s2.0-0034634281
12. Griendling K. K., Sorescu D., Ushio-Fukai M., NAD(P)H oxidase: role in cardiovascular biology and disease. Circulation Research 2000 86 5 494 501 2-s2.0-0034677947 (Pubitemid 30165039)
13. Kelley E. E., Khoo N. K. H., Hundley N. J., Malik U. Z., Freeman B. A., Tarpey M. M., Hydrogen peroxide is the major oxidant product of xanthine oxidase. Free Radical Biology and Medicine 2010 48 4 493 498 2-s2.0-74249101108 10.1016/j.freeradbiomed.2009.11.012
14. Yokoyama Y., Beckman J. S., Beckman T. K., Wheat J. K., Cash T. G., Freeman B. A., Parks D. A., Circulating xanthine oxidase: potential mediator of ischemic injury. American Journal of Physiology 1990 258 4 G564 G570 2-s2.0-0025312326 (Pubitemid 20144076)
15. Taverne Y. J., de Beer V. J., Hoogteijling B. A., Juni R. P., Moens A. L., Duncker D. J., Merkus D., Nitroso-redox balance in control of coronary vasomotor tone. Journal of Applied Physiology 2012 112 10 1644 1652 10.1152/japplphysiol.00479.2011
16. Andrew P. J., Mayer B., Enzymatic function of nitric oxide synthases. Cardiovascular Research 1999 43 3 521 531 2-s2.0-0033567065 10.1016/S0008- 6363(99)00115-7 (Pubitemid 29369251)
17. Cosentino F., Lüscher T. F., Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovascular Research 1999 43 2 274 278 2-s2.0-0344052668 10.1016/S0008-6363(99)00134-0 (Pubitemid 29356362)
18. Kawashima S., Yokoyama M., Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 6 998 1005 2-s2.0-2942610581 10.1161/01.ATV.0000125114.88079.96 (Pubitemid 38737823)
19. Suwaidi J. A., Hamasaki S., Higano S. T., Nishimura R. A., Holmes D. R., Lerman A., Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000 101 9 948 954 2-s2.0-0001654669 (Pubitemid 30131694)
20. Liu Q., Berchner-Pfannschmidt U., Möller U., Brecht M., Wotzlaw C., Acker H., Jungermann K., Kietzmann T., A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proceedings of the National Academy of Sciences of the United States of America 2004 101 12 4302 4307 2-s2.0-1642447143 10.1073/pnas.0400265101 (Pubitemid 38405924)
21. Cadenas S., Aragonés J., Landázuri M. O., Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease. Cardiovascular Research 2010 88 2 219 228 2-s2.0-77956605222 10.1093/cvr/cvq256
22. Thannickal V. J., Fanburg B. L., Reactive oxygen species in cell signaling. American Journal of Physiology 2000 279 6 L1005 L1028 2-s2.0-0034533082 (Pubitemid 32009487)
23. Chakravarthi S., Jessop C. E., Bulleid N. J., The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress. EMBO Reports 2006 7 3 271 275 2-s2.0-33645784167 10.1038/sj.embor.7400645
24. Shen D., Dalton T. P., Nebert D. W., Shertzer H. G., Glutathione redox state regulates mitochondrial reactive oxygen production. Journal of Biological Chemistry 2005 280 27 25305 25312 2-s2.0-21844446870 10.1074/jbc.M500095200 (Pubitemid 40962232)
25. Masella R., Di Benedetto R., Varì R., Filesi C., Giovannini C., Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. Journal of Nutritional Biochemistry 2005 16 10 577 586 2-s2.0-25144482448 10.1016/j.jnutbio.2005.05.013 (Pubitemid 41338369)
26. Pastore A., Federici G., Bertini E., Piemonte F., Analysis of glutathione: implication in redox and detoxification. Clinica Chimica Acta 2003 333 1-2 19 39 2-s2.0-0037505644 10.1016/S0009-8981(03)00200-6 (Pubitemid 36694824)
27. Townsend D. M., Tew K. D., Tapiero H., The importance of glutathione in human disease. Biomedicine and Pharmacotherapy 2003 57 3 145 155 2-s2.0-0037733975 10.1016/S0753-3322(03)00043-X (Pubitemid 36740460)
28. Knock G. A., Ward J. P. T., Redox regulation of protein kinases as a modulator of vascular function. Antioxidants and Redox Signaling 2011 15 6 1531 1547 2-s2.0-79961191673 10.1089/ars.2010.3614
29. Burgoyne J. R., Mongue-Din H., Eaton P., Shah A. M., Redox signaling in cardiac physiology and pathology. Circulation Research 2012 111 8 1091 1106
30. Steinberg S. F., Oxidative stress and sarcomeric proteins. Circulation Research 2013 112 2 393 405
31. Surma M., Wei L., Shi J., Rho kinase as a therapeutic target in cardiovascular disease. Future Cardiology 2011 7 5 657 671
32. Satoh K., Fukumoto Y., Shimokawa H., Rho-kinase: important new therapeutic target in cardiovascular diseases. American Journal of Physiology 2011 301 2 H287 H296 2-s2.0-79961067803 10.1152/ajpheart.00327.2011
33. Michel M. C., Li Y., Heusch G., Mitogen-activated protein kinases in the heart. Naunyn-Schmiedeberg's Archives of Pharmacology 2001 363 3 245 266 2-s2.0-0035115055 10.1007/s002100000363 (Pubitemid 32186523)
34. Martindale J. L., Holbrook N. J., Cellular response to oxidative stress: signaling for suicide and survival. Journal of Cellular Physiology 2002 192 1 1 15 2-s2.0-0036260697 10.1002/jcp.10119 (Pubitemid 34587382)
35. Johnson G. L., Lapadat R., Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002 298 5600 1911 1912 2-s2.0-0037032817 10.1126/science.1072682 (Pubitemid 35425238)
36. Morgan M. J., Liu Z. G., Crosstalk of reactive oxygen species and NF- B signaling. Cell Research 2011 21 1 103 115 2-s2.0-78650894319 10.1038/cr.2010.178
37. Bonello S., Zahringer C., BelAiba R. S., Djordjevic T., Hess J., Michiels C., Kietzmann T., Gorlach A., Reactive oxygen species activate the HIF-1 α promoter via a functional NF B site. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 755 761 (Pubitemid 46606703)
38. Hattori R., Otani H., Uchiyama T., Imamura H., Cui J., Maulik N., Cordis G. A., Zhu L., Das D. K., Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. American Journal of Physiology 2001 281 3 H1066 H1074 2-s2.0-0034836649
39. Maulik N., Sasaki H., Galang N., Differential regulation of apoptosis by ischemia-reperfusion and ischemic adaptation. Annals of the New York Academy of Sciences 1999 874 401 411 2-s2.0-0032804983 10.1111/j.1749-6632.1999.tb09254.x (Pubitemid 29351960)
40. Maulik N., Yoshida T., Das D. K., Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase. Molecular and Cellular Biochemistry 1999 196 1-2 13 21 2-s2.0-0032775912 10.1023/A: 1006905910140 (Pubitemid 29338774)
41. Becker L. B., New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovascular Research 2004 61 3 461 470 2-s2.0-1142297598 10.1016/j.cardiores.2003.10.025 (Pubitemid 38210152)
42. Maulik N., Engelman R. M., Rousou J. A., Flack J. E., Deaton D., Das D. K., Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 1999 100 19 II369 II375 2-s2.0-0344339188 (Pubitemid 29523563)
43. Maulik N., Goswami S., Galang N., Das D. K., Differential regulation of Bcl-2, AP-1 and NF- B on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Letters 1999 443 3 331 336 2-s2.0-0033066832 10.1016/S0014-5793(98)01719-0 (Pubitemid 29080821)
44. Adams J. M., Cory S., The Bcl-2 protein family: arbiters of cell survival. Science 1998 281 5381 1322 1326 2-s2.0-0032575688 (Pubitemid 28406819)
45. Hattori R., Estrada Hernandez T., Zhu L., Maulik N., Otani H., Kaneda Y., Das D. K., An essential role of the antioxidant gene bcl-2 in myocardial adaptation to ischemia: an insight with antisense bcl-2 therapy. Antioxidants and Redox Signaling 2001 3 3 403 413 2-s2.0-0034938158 (Pubitemid 32646032)
46. Xia Z., Liu M., Wu Y., Sharma V., Luo T., Ouyang J., McNeill J. H., N-acetylcysteine attenuates TNF- α -induced human vascular endothelial cell apoptosis and restores eNOS expression. European Journal of Pharmacology 2006 550 1-3 134 142 2-s2.0-33749992417 10.1016/j.ejphar.2006.08.044 (Pubitemid 44572264)
47. Virdis A., Santini F., Colucci R., Duranti E., Salvetti G., Rugani I., Segnani C., Anselmino M., Bernardini N., Blandizzi C., Salvetti A., Pinchera A., Taddei S., Vascular generation of tumor necrosis factor- α reduces nitric oxide availability in small arteries from visceral fat of obese patients. Journal of the American College of Cardiology 2011 58 3 238 247 2-s2.0-79960057777 10.1016/j.jacc.2011.01.050
48. Zou W., Amcheslavsky A., Takeshita S., Drissi H., Bar-Shavit Z., TNF- α expression is transcriptionally regulated by RANK ligand. Journal of Cellular Physiology 2005 202 2 371 378 2-s2.0-11144282704 10.1002/jcp.20127 (Pubitemid 40041307)
49. Zhang H., Park Y., Wu J., Chen X. P., Lee S., Yang J., Dellsperger K. C., Zhang C., Role of TNF- α in vascular dysfunction. Clinical Science 2009 116 3 219 230 10.1042/CS20080196
50. Gao X., Zhang H., Belmadani S., Wu J., Xu X., Elford H., Potter B. J., Zhang C., Role of TNF- α -induced reactive oxygen species in endothelial dysfunction during reperfusion injury. American Journal of Physiology 2008 295 6 H2242 H2249 2-s2.0-57349197115 10.1152/ajpheart.00587.2008
51. Guzik T. J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., Channon K. M., Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002 105 14 1656 1662 2-s2.0-0037046214 10.1161/01.CIR.0000012748.58444.08 (Pubitemid 34298608)
52. Stephens N. G., Parsons A., Schofield P. M., Kelly F., Cheeseman K., Mitchinson M. J., Brown M. J., Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). The Lancet 1996 347 9004 781 786 2-s2.0-0029925181 10.1016/S0140-6736(96)90866-1 (Pubitemid 26091640)
53. Duffy S. J., Gokce N., Holbrook M., Huang A., Frei B., Keaney J. F., Vita J. A., Treatment of hypertension with ascorbic acid. The Lancet 1999 354 9195 2048 2049 2-s2.0-0033547645 10.1016/S0140-6736(99)04410-4
54. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M. S., Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. The Lancet 2000 356 9237 1213 1218 2-s2.0-0034619027
55. Neri S., Signorelli S. S., Torrisi B., Pulvirenti D., Mauceri B., Abate G., Ignaccolo L., Bordonaro F., Cilio D., Calvagno S., Leotta C., Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. Clinical Therapeutics 2005 27 11 1764 1773 2-s2.0-29144455353 10.1016/j.clinthera.2005.11.006 (Pubitemid 41815227)
56. Accinni R., Rosina M., Bamonti F., Della Noce C., Tonini A., Bernacchi F., Campolo J., Caruso R., Novembrino C., Ghersi L., Lonati S., Grossi S., Ippolito S., Lorenzano E., Ciani A., Gorini M., Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutrition, Metabolism & Cardiovascular Diseases 2006 16 2 121 127 (Pubitemid 43384709)
57. Hennekens C. H., Buring J. E., Manson J. E., Stampfer M., Rosner B., Cook N. R., Belanger C., Lamotte F., Gaziano J. M., Ridker P. M., Willett W., Peto R., Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. The New England Journal of Medicine 1996 334 18 1145 1149 2-s2.0-0345157579 10.1056/ NEJM199605023341801 (Pubitemid 26137972)
58. Rapola J. M., Virtamo J., Ripatti S., Huttunen J. K., Albanes D., Taylor P. R., Heinonen O. P., Randomised trial of α -tocopherol and β -carotene supplements on incidence of major coronary events in men with previous myocardial infarction. The Lancet 1997 349 9067 1715 1720 2-s2.0-0030916162 10.1016/S0140-6736(97)01234-8 (Pubitemid 27252669)
59. Virtamo J., Rapola J. M., Ripatti S., Heinonen O. P., Taylor P. R., Albanes D., Huttunen J. K., Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Archives of Internal Medicine 1998 158 6 668 675 2-s2.0-0032559780 10.1001/archinte.158.6.668 (Pubitemid 28144826)
60. Italiano G., Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. The Lancet 1999 354 9177 447 455
61. Yusuf S., Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The New England Journal of Medicine 2000 342 3 145 153 2-s2.0-0034688194 10.1056/ NEJM200001203420301 (Pubitemid 30051645)
62. de Gaetano G., Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. The Lancet 2001 357 9250 89 95 2-s2.0-0035852471 10.1016/S0140-6736(00)03539-X (Pubitemid 32094910)
63. Collins R., Armitage J., Parish S., Sleight P., Peto R., MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. The Lancet 2002 360 9326 23 33 2-s2.0-0037031094 10.1016/S0140-6736(02)09328-5 (Pubitemid 34756488)
64. Törnwall M. E., Virtamo J., Korhonen P. A., Virtanen M. J., Taylor P. R., Albanes D., Huttunen J. K., Effect of α -tocopherol and β -carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. European Heart Journal 2004 25 13 1171 1178 2-s2.0-3042621001 10.1016/j.ehj.2004.05.007 (Pubitemid 38834075)
65. Armitage J., Collins R., Bowman L., Parish S., Sleight P., Peto R., Meade T., Youngman L., Buxton M., de Bono D., George C., Fuller J., Keech A., Mansfield A., Pentecost B., Simpson D., Warlow C., McNamara J., O'Toole L., Benjamin N., Webster J., Jamieson J., Donald L., Blandford R., Carrington L., McMahon H., Cheetham D., Reckless J., Brice L., Carpenter R., Christmas J., Flower C., Cooper I., Frampton S., Pickerell E., Wells J., Scott M., Crowe V., Shaw A., Shannon L., Jones S., Faulkner G., Lavery A., O'Leary H., Watson R., Capewell C., Hughes S., Bain S., Jones A., Holmes G., Jewkes C., Bellamy T., Harrison P., Buller N., Hooks J., Jones H., Smith E., Vint P., Watson R., Crook P., Williams J., Bateson M., Cawley P., Gill P., Hawkeswell L., Simpson K., Armitage M., Cope C., Tricksey J., Wilson M., Cottrell S., Jones C., Llewellyn M., Smith P., Woodsford T., Vincent R., Joyce E., Skipper N., Peters P., Lemon M., Stansbie D., Kidan A. H., Halestap M., Gibbons A., Meredith J., Dawkins C., Papouchado M., Baker L., Boulton K., Dawe C., Lewis A., Wisby J., Brown M., Emeny J., Smith W., Thurston D., Trutwein D., Cornwell M., Lloyd D., The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]. BMC Medicine 2005 3, article 6 2-s2.0-27544452472 10.1186/1741-7015-3-6 (Pubitemid 41534989)
66. Cook N. R., Albert C. M., Gaziano J. M., Zaharris E., MacFadyen J., Danielson E., Buring J. E., Manson J. E., A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the women's antioxidant cardiovascular study. Archives of Internal Medicine 2007 167 15 1610 1618 2-s2.0-34548040480 10.1001/archinte.167.15.1610 (Pubitemid 47280341)
67. Lee I. M., Cook N. R., Gaziano J. M., Gordon D., Ridker P. M., Manson J. E., Hennekens C. H., Buring J. E., Vitamin E in the primary prevention of cardiovascular disease and cancer. The women's health study: a randomized controlled trial. Journal of the American Medical Association 2005 294 1 56 65 2-s2.0-21444438990 10.1001/jama.294.1.56 (Pubitemid 41002839)
68. Lonn E., Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. Journal of the American Medical Association 2005 293 11 1338 1347 2-s2.0-20044383911 10.1001/jama.293.11.1338 (Pubitemid 40381486)
69. Kataja-Tuomola M. K., Kontto J. P., Männistö S., Albanes D., Virtamo J. R., Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: results of the ATBC study. Annals of Medicine 2010 42 3 178 186 2-s2.0-77950789625 10.3109/07853890903508887
70. Ushio-Fukai M., Alexander R. W., Reactive oxygen species as mediators of angiogenesis signaling. Role of NAD(P)H oxidase. Molecular and Cellular Biochemistry 2004 264 1-2 85 97 2-s2.0-5544237716 10.1023/B:MCBI.0000044378. 09409.b5 (Pubitemid 39366107)
71. Lambeth J. D., NOX enzymes and the biology of reactive oxygen. Nature Reviews Immunology 2004 4 3 181 189 2-s2.0-1542406446 (Pubitemid 38339084)
72. Sedeek M., Montezano A. C., Hebert R. L., Gray S. P., Di Marco E., Jha J. C., Cooper M. E., Jandeleit-Dahm K., Schiffrin E. L., Wilkinson-Berka J. L., Touyz R. M., Oxidative stress, Nox isoforms and complications of diabetes-potential targets for novel therapies. Journal of Cardiovascular Translational Research 2012 5 4 509 518 10.1007/s12265-012-9387-2
73. Murdoch C. E., Alom-Ruiz S. P., Wang M., Zhang M., Walker S., Yu B., Brewer A., Shah A. M., Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Research in Cardiology 2011 106 4 527 538 2-s2.0-79959704368 10.1007/s00395-011-0179-7
74. Rhee S. G., Kang S. W., Jeong W., Chang T. S., Yang K. S., Woo H. A., Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Current Opinion in Cell Biology 2005 17 2 183 189 2-s2.0-15044362438 10.1016/j.ceb.2005.02.004 (Pubitemid 40380942)
75. Catarzi S., Giannoni E., Favilli F., Meacci E., Iantomasi T., Vincenzini M. T., Sphingosine 1-phosphate stimulation of NADPH oxidase activity: relationship with platelet-derived growth factor receptor and c-Src kinase. Biochimica et Biophysica Acta 2007 1770 6 872 883 2-s2.0-34247263678 10.1016/j.bbagen.2007.01.008 (Pubitemid 46617027)
76. Schröder E., Brennan J. P., Eaton P., Cardiac peroxiredoxins undergo complex modifications during cardiac oxidant stress. American Journal of Physiology 2008 295 1 H425 H433 2-s2.0-49849106655 10.1152/ajpheart.00017.2008
77. Jeong W., Bae S. H., Toledano M. B., Rhee S. G., Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression. Free Radical Biology & Medicine 2012 53 3 447 456 10.1016/j.freeradbiomed.2012. 05.020
78. Malinouski M., Zhou Y., Belousov V. V., Hatfield D. L., Gladyshev V. N., Hydrogen peroxide probes directed to different cellular compartments. PLoS ONE 2011 6 1 2-s2.0-79251603273 10.1371/journal.pone.0014564 e14564
79. Bienert G. P., Møller A. L. B., Kristiansen K. A., Schulz A., Møller I. M., Schjoerring J. K., Jahn T. P., Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. Journal of Biological Chemistry 2007 282 2 1183 1192 2-s2.0-33847753534 10.1074/jbc.M603761200 (Pubitemid 47076557)
80. Edwards G., Thollon C., Gardener M. J., Félétou M., Vilaine J. P., Vanhoutte P. M., Weston A. H., Role of gap junctions and EETs in endothelium-dependent hyperpolarization of porcine coronary artery. British Journal of Pharmacology 2000 129 6 1145 1154 2-s2.0-0034061942 (Pubitemid 30153971)
81. Matoba T., Shimokawa H., Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. Journal Pharmacological Sciences 2003 92 1 1 6 2-s2.0-0037704176 (Pubitemid 36705661)
82. Shimokawa H., Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflugers Archiv European Journal of Physiology 2010 459 6 915 922 2-s2.0-77952889385 10.1007/s00424-010-0790-8
83. Deshpande N. N., Sorescu D., Seshiah P., Ushio-Fukai M., Akers M., Yin Q., Griendling K. K., Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxidants and Redox Signaling 2002 4 5 845 854 2-s2.0-0036774407 (Pubitemid 35246948)
84. 2-induced apoptosis through functional codependence between HO-1 and AKT. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 9 2027 2034 2-s2.0-33747412943 10.1161/01.ATV.0000236204.37119.8d (Pubitemid 44253784)
85. Pletjushkina O. Y., Fetisova E. K., Lyamzaev K. G., Ivanova O. Y., Domnina L. V., Vyssokikh M. Y., Pustovidko A. V., Vasiliev J. M., Murphy M. P., Chernyak B. V., Skulachev V. P., Long-distance apoptotic killing of cells is mediated by hydrogen peroxide in a mitochondrial ROS-dependent fashion. Cell Death and Differentiation 2005 12 11 1442 1444 2-s2.0-27344451573 10.1038/sj.cdd.4401685 (Pubitemid 41521935)
86. Skulachev V. P., Anisimov V. N., Antonenko Y. N., Bakeeva L. E., Chernyak B. V., Erichev V. P., Filenko O. F., Kalinina N. I., Kapelko V. I., Kolosova N. G., Kopnin B. P., Korshunova G. A., Lichinitser M. R., Obukhova L. A., Pasyukova E. G., Pisarenko O. I., Roginsky V. A., Ruuge E. K., Senin I. I., Severina I. I., Skulachev M. V., Spivak I. M., Tashlitsky V. N., Tkachuk V. A., Vyssokikh M. Y., Yaguzhinsky L. S., Zorov D. B., An attempt to prevent senescence: a mitochondrial approach. Biochimica et Biophysica Acta 2009 1787 5 437 461 10.1016/j.bbabio.2008.12.008
87. 2 for platelet-derived growth factor signal transduction. Science 1995 270 5234 296 299 2-s2.0-0028973482
88. Weber D. S., Taniyama Y., Rocic P., Seshiah P. N., Dechert M. A., Gerthoffer W. T., Griendling K. K., Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circulation Research 2004 94 9 1219 1226 2-s2.0-2442666453 10.1161/01.RES.0000126848.54740.4A (Pubitemid 38656408)
89. Bleeke T., Zhang H., Madamanchi N., Patterson C., Faber J. E., Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circulation Research 2004 94 1 37 45 2-s2.0-0346059582 10.1161/01.RES.0000109412.80157.7D (Pubitemid 38064096)
90. Gurjar M. V., Sharma R. V., Bhalla R. C., eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 12 2871 2877 2-s2.0-0033387969 (Pubitemid 30029812)
91. Rajagopalan S., Meng X. P., Ramasamy S., Harrison D. G., Galis Z. S., Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. Journal of Clinical Investigation 1996 98 11 2572 2579 2-s2.0-10544246489 (Pubitemid 26415078)
92. Liang H., Ran Q., Jang Y. C., Holstein D., Lechleiter J., McDonald-Marsh T., Musatov A., Song W., Van Remmen H., Richardson A., Glutathione peroxidase 4 differentially regulates the release of apoptogenic proteins from mitochondria. Free Radical Biology and Medicine 2009 47 3 312 320 2-s2.0-67349227428 10.1016/j.freeradbiomed.2009.05.012
93. Bolli R., Jeroudi M. O., Patel B. S., DuBose C. M., Lai E. K., Roberts R., McCay P. B., Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proceedings of the National Academy of Sciences of the United States of America 1989 86 12 4695 4699 2-s2.0-0001371023 (Pubitemid 19164616)
94. Simoons M. L., Serruys P. W., Van den Brand M., Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. Journal of the American College of Cardiology 1986 7 4 717 728 2-s2.0-0022652052 (Pubitemid 16107115)
95. White H. D., Norris R. M., Brown M. A., Takayama M., Maslowski A., Bass N. M., Ormiston J. A., Whitlock T., Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. The New England Journal of Medicine 1987 317 14 850 855 2-s2.0-0023272787 (Pubitemid 17156728)
96. Toyokuni S., Reactive oxygen species-induced molecular damage and its application in pathology. Pathology International 1999 49 2 91 102 2-s2.0-0033041916 10.1046/j.1440-1827.1999.00829.x (Pubitemid 29133467)
97. Majidi M., Kosinski A. S., Al-Khatib S. M., Lemmert M. E., Smolders L., Van Weert A., Reiber J. H. C., Tzivoni D., Bär F. W. H. M., Wellens H. J. J., Gorgels A. P. M., Krucoff M. W., Reperfusion ventricular arrhythmia "bursts" predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction. European Heart Journal 2009 30 7 757 764 2-s2.0-64849106460 10.1093/eurheartj/ ehp005
98. Vaage J., Antonelli M., Bufi M., Irtun Ö., Deblasi R. A., Corbucci G. G., Gasparetto A., Semb A. G., Exogenous reactive oxygen species deplete the isolated rat heart of antioxidants. Free Radical Biology and Medicine 1996 22 1-2 85 92 2-s2.0-0030636188 10.1016/S0891-5849(96)00278-X (Pubitemid 26399313)
99. Gori T., Di Stolfo G., Sicuro S., Dragoni S., Lisi M., Forconi S., Parker J. D., Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight. British Journal of Clinical Pharmacology 2007 64 2 145 150 2-s2.0-34447338084 10.1111/j.1365-2125.2007.02864.x (Pubitemid 47063243)
100. Penna C., Mognetti B., Tullio F., Gattullo D., Mancardi D., Pagliaro P., Alloatti G., The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling. Journal of Physiology and Pharmacology 2008 59 1 47 54 2-s2.0-42049089287 (Pubitemid 351520162)
101. Lebuffe G., Schumacker P. T., Shao Z. H., Anderson T., Iwase H., Vanden Hoek T. L., ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. American Journal of Physiology 2003 284 1 H299 H308 2-s2.0-0037230180 (Pubitemid 36076298)
102. Oldenburg O., Cohen M. V., Yellon D. M., Downey J. M., Mitochondrial KATP channels: role in cardioprotection. Cardiovascular Research 2002 55 3 429 437 10.1016/S0008-6363(02)00439-X (Pubitemid 34874938)
103. Pain T., Yang X. M., Critz S. D., Yue Y., Nakano A., Liu G. S., Heusch G., Cohen M. V., Downey J. M., Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circulation Research 2000 87 6 460 466 2-s2.0-0034665065
104. Heinzel F. R., Luo Y., Li X., Boengler K., Buechert A., García-Dorado D., Di Lisa F., Schulz R., Heusch G., Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circulation Research 2005 97 6 583 586 2-s2.0-25444512382 10.1161/01.RES.0000181171.65293.65 (Pubitemid 41361749)
105. Laude K., Thuillez C., Richard V., Peroxynitrite triggers a delayed resistance of coronary endothelial cells against ischemia-reperfusion injury. American Journal of Physiology 2002 283 4 H1418 H1423 2-s2.0-0036783944
106. Rakhit R. D., Edwards R. J., Mockridge J. W., Baydoun A. R., Wyatt A. W., Mann G. E., Marber M. S., Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes. American Journal of Physiology 2000 278 4 H1211 H1217 2-s2.0-0034055897 (Pubitemid 30235498)
107. Navab M., Berliner J. A., Watson A. D., Hama S. Y., Territo M. C., Lusis A. J., Shih D. M., Van Lenten B. J., Frank J. S., Demer L. L., Edwards P. A., Fogelman A. M., The Yin and Yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff memorial lecture. Arteriosclerosis, Thrombosis, and Vascular Biology 1996 16 7 831 842 2-s2.0-8944258922 (Pubitemid 26234980)
108. Berk B. C., Abe J. I., Min W., Surapisitchat J., Yan C., Endothelial atheroprotective and anti-inflammatory mechanisms. Annals of the New York Academy of Sciences 2001 947 93 111 10.1111/j.1749-6632.2001.tb03932.x (Pubitemid 34059905)
109. Godbole A. S., Lu X., Guo X., Kassab G. S., NADPH oxidase has a directional response to shear stress. American Journal of Physiology 2009 296 1 H152 H158 2-s2.0-58149492420 10.1152/ajpheart.01251.2007
110. Hwang J., Saha A., Boo Y. C., Sorescu G. P., McNally J. S., Holland S. M., Dikalov S., Giddens D. P., Griendling K. K., Harrison D. G., Jo H., Oscillatory shear stress stimulates endothelial production of O2- from p47phox -dependent NAD(P)H oxidases, leading to monocyte adhesion. Journal of Biological Chemistry 2003 278 47 47291 47298 2-s2.0-10744220574 10.1074/jbc.M305150200 (Pubitemid 37452318)
111. Walpola P. L., Gotlieb A. I., Cybulsky M. I., Langille B. L., Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 1 2 10 2-s2.0-0028909793
112. Tinkel J., Hassanain H., Khouri S. J., Cardiovascular antioxidant therapy: a review of supplements, pharmacotherapies, and mechanisms. Cardiology in Review 2012 20 2 77 83
113. Gey K. F., Puska P., Jordan P., Moser U. K., Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. American Journal of Clinical Nutrition 1991 53 1 2-s2.0-0026025851
114. Fisher A. B., Redox signaling across cell membranes. Antioxidants and Redox Signaling 2009 11 6 1349 1356 2-s2.0-65349100528 10.1089/ars.2008.2378
115. Vivekananthan D. P., Penn M. S., Sapp S. K., Hsu A., Topol E. J., Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. The Lancet 2003 361 9374 2017 2023 2-s2.0-0037840165 10.1016/S0140-6736(03)13637-9 (Pubitemid 36695043)
116. Myung S. K., Ju W., Cho B., Oh S. W., Park S. M., Koo B. K., Park B. J., Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013 346 f10 10.1136/bmj.f10
117. Bjelakovic G., Nikolova D., Gluud L. L., Simonetti R. G., Gluud C., Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews 2008 2 CD007176 2-s2.0-44949136378
118. McGregor G. P., Biesalski H. K., Rationale and impact of vitamin C in clinical nutrition. Current Opinion in Clinical Nutrition and Metabolic Care 2006 9 6 697 703 2-s2.0-33750349108 10.1097/01.mco.0000247478.79779.8f (Pubitemid 44624616)
119. Münzel T., Gori T., Bruno R. M., Taddei S., Is oxidative stress a therapeutic target in cardiovascular disease? European Heart Journal 2010 31 22 2741 2749 2-s2.0-78649357316 10.1093/eurheartj/ehq396
120. Boschi D., Tron G. C., Lazzarato L., Chegaev K., Cena C., Di Stilo A., Giorgis M., Bertinaria M., Fruttero R., Gasco A., NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties. Journal of
121. Serebruany V., Malinin A., Scott R., The in vitro effects of a novel vascular protectant, AGI-1067, on platelet aggregation and major receptor expression in subjects with multiple risk factors for vascular disease. Journal of Cardiovascular Pharmacology and Therapeutics 2006 11 3 191 196 2-s2.0-33749574567 10.1177/1074248406290598 (Pubitemid 44536187)
122. Zhang Q., Pan J., Zhao C., Wang Y., Jia Z., Zheng R., Non-enzymatic fast repair of DNA oxidative damage might also exist in cells. Cell Biology International 2008 32 6 654 662 2-s2.0-43249131870 10.1016/j.cellbi.2008.01.291
123. O'Connor P. M., Gutterman D. D., Resurrecting hope for antioxidant treatment of cardiovascular disease: focus on mitochondria. Circulation Research 2010 107 1 9 11 2-s2.0-77954723691 10.1161/CIRCRESAHA.110.223321
124. Dikalova A. E., Bikineyeva A. T., Budzyn K., Nazarewicz R. R., McCann L., Lewis W., Harrison D. G., Dikalov S. I., Therapeutic targeting of mitochondrial superoxide in hypertension. Circulation Research 2010 107 1 106 116 2-s2.0-77954698808 10.1161/CIRCRESAHA.109.214601
125. Davidson S. M., Endothelial mitochondria and heart disease. Cardiovascular Research 2010 88 1 58 66 2-s2.0-77956589962 10.1093/cvr/cvq195
126. Subramanian S., Kalyanaraman B., Migrino R. Q., Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases. Recent Patents on Cardiovascular Drug Discovery 2010 5 1 54 65 2-s2.0-77951143920 10.2174/157489010790192601
127. Skulachev M. V., Antonenko Y. N., Anisimov V. N., Chernyak B. V., Cherepanov D. A., Chistyakov V. A., Egorov M. V., Kolosova N. G., Korshunova G. A., Lyamzaev K. G., Plotnikov E. Y., Roginsky V. A., Savchenko A. Y., Severina I. I., Severin F. F., Shkurat T. P., Tashlitsky V. N., Shidlovsky K. M., Vyssokikh M. Y., Zamyatnin A. A., Zorov D. B., Skulachev V. P., Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies. Current Drug Targets 2011 12 6 800 826 2-s2.0-79955595082 10.2174/138945011795528859
128. Dai D. F., Johnson S. C., Villarin J. J., Chin M. T., Nieves-Cintrón M., Chen T., Marcinek D. J., Dorn G. W., Kang Y. J., Prolla T. A., Santana L. F., Rabinovitch P. S., Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and G α q overexpression-induced heart failure. Circulation Research 2011 108 7 837 846 2-s2.0-79954694973 10.1161/CIRCRESAHA.110.232306